Pharmacovigilance

Ibn Al-Haytham Pharmaceutical Industries believes that the quality of medicine is incomplete without ensuring its safety. Therefore, we prioritize "Pharmacovigilance" as an integrated pharmaceutical system aimed at monitoring, assessing, understanding, and preventing all side effects related to medicines, in line with World Health Organization (WHO) standards.

What is Pharmacovigilance?

It is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects. Our role does not end when a drug is launched in the market; it extends to monitoring its performance under real-life clinical conditions and across a broad spectrum of patients to ensure the highest levels of clinical safety.

Our specialized team works toward the following goals:

• Early Detection: Monitoring any new or unexpected side effects as soon as they appear.
• Frequency Analysis: Monitoring the prevalence of side effects to assess the safety of continuous use.
• Risk Identification: Identifying predisposing factors for side effects to provide more accurate guidance.

• Preventive Management: Implementing essential regulatory and medical procedures to minimize risks and promote a culture of safe use.

What is a Side Effect?
It is an unintended and harmful response resulting from the use of a medicinal product, whether at recommended doses, or due to misuse or overdose.

Why do symptoms appear that are not mentioned in the internal leaflet?
Medicines undergo extensive clinical studies before marketing, but these studies are conducted on limited numbers and for specific periods. Once a drug is released for general use, its effects appear on millions of patients over many years, which may reveal very rare symptoms that did not appear previously. This highlights the importance of "Post-Marketing Surveillance" as an additional safeguard for your health.

Ibn Al-Haytham allows physicians, pharmacists, and consumers to report any side effects or product quality issues. Your report is more than just information; it is a vital step in enhancing drug safety and protecting other patients.

Direct Communication Channels:
You can send your reports through electronic form: Click here to fill out the reporting form.

Ibn Al-Haytham is committed to the highest levels of confidentiality and privacy. All information contained in reports, including the identity of the patient and the reporter, is treated as strictly protected data and will not be disclosed to any unauthorized party under any circumstances. It is used exclusively for evaluating pharmaceutical safety.

Note: Filling out the form may take a few minutes, but your contribution is the cornerstone of the journey to develop healthcare and ensure a safer future for all.